151 related articles for article (PubMed ID: 38681349)
1. Unraveling the Enigma: A Five-Year Comprehensive Analysis of Hurthle Cell Tumors in South India's Tertiary Care Center.
Sulaiman S; Chirukandath R; Krishnan SK; Rajesh N; Antony M; Mohan K; S S
Cureus; 2024 Mar; 16(3):e57166. PubMed ID: 38681349
[TBL] [Abstract][Full Text] [Related]
2. [Hürthle-cell thyroid neoplasms: a clinical enigma].
Cannizzaro M; Fiorenza G; Garofalo L; De Maria A; Cavallaro N; Pulvirenti A; Veroux PF
Ann Ital Chir; 1999; 70(4):503-8; discussion 508-9. PubMed ID: 10573612
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
[TBL] [Abstract][Full Text] [Related]
4. Hurthle cell neoplasms of thyroid in south-western region of Saudi Arabia.
Al-Shraim MM; Hussein MR; Musalam AO; Al-Ghandi T; Al-Zahramit H; Mahrouz AA; Abu-Eshy SA
West Afr J Med; 2010; 29(6):398-402. PubMed ID: 21465448
[TBL] [Abstract][Full Text] [Related]
5. Appearance of Hürthle cell carcinoma soon after surgical extirpation of Hürthle cell adenoma and follicular adenoma of the thyroid gland.
Ristevska N; Stojanoski S; Gjorceva DP
Radiol Oncol; 2015 Mar; 49(1):26-31. PubMed ID: 25810698
[TBL] [Abstract][Full Text] [Related]
6. Unilateral lobectomy for Hurthle cell adenoma.
Wasvary H; Czako P; Poulik J; Lucas R
Am Surg; 1998 Aug; 64(8):729-32; discussion 732-3. PubMed ID: 9697901
[TBL] [Abstract][Full Text] [Related]
7. Hürthle cell tumors: a twenty-five-year experience.
Arganini M; Behar R; Wu TC; Straus F; McCormick M; DeGroot LJ; Kaplan EL
Surgery; 1986 Dec; 100(6):1108-15. PubMed ID: 3787466
[TBL] [Abstract][Full Text] [Related]
8. Management considerations in Hürthle cell carcinoma.
Azadian A; Rosen IB; Walfish PG; Asa SL
Surgery; 1995 Oct; 118(4):711-4; discussion 714-5. PubMed ID: 7570326
[TBL] [Abstract][Full Text] [Related]
9. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
10. Preoperative serum thyroglobulin concentration as a predictive factor of malignancy in small follicular and Hürthle cell neoplasms of the thyroid gland.
Petric R; Besic H; Besic N
World J Surg Oncol; 2014 Sep; 12():282. PubMed ID: 25213012
[TBL] [Abstract][Full Text] [Related]
11. Hürthle cell tumors: applying molecular markers to define a new management algorithm.
Maxwell EL; Palme CE; Freeman J
Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):54-8. PubMed ID: 16415430
[TBL] [Abstract][Full Text] [Related]
12. Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid.
Erickson LA; Jin L; Goellner JR; Lohse C; Pankratz VS; Zukerberg LR; Thompson GB; van Heerden JA; Grant CS; Lloyd RV
Mod Pathol; 2000 Feb; 13(2):186-92. PubMed ID: 10697277
[TBL] [Abstract][Full Text] [Related]
13. Fine needle aspiration of poorly differentiated oxyphilic (Hürthle cell) thyroid carcinoma: a case report.
Ghofrani M; Sosa JA; Ocal IT; Angeletti C
Acta Cytol; 2006; 50(5):560-2. PubMed ID: 17017447
[TBL] [Abstract][Full Text] [Related]
14. Hürthle cell neoplasms of the thyroid: are there factors predictive of malignancy?
Chen H; Nicol TL; Zeiger MA; Dooley WC; Ladenson PW; Cooper DS; Ringel M; Parkerson S; Allo M; Udelsman R
Ann Surg; 1998 Apr; 227(4):542-6. PubMed ID: 9563543
[TBL] [Abstract][Full Text] [Related]
15. Hurthle cell tumor.
Chen HY; Benjamin LB; Chen MF
Int Surg; 1996; 81(2):168-70. PubMed ID: 8912085
[TBL] [Abstract][Full Text] [Related]
16. Hurthle cell neoplasm of the thyroid gland.
Ahmed M; Bin Yousef H; Greer W; Faraz H; Al Sobhi S; Al Zahrani A; Raef H; Al Ghamdi A; Al Kadhi Y; Al Dayel F
ANZ J Surg; 2008 Mar; 78(3):139-43. PubMed ID: 18269475
[TBL] [Abstract][Full Text] [Related]
17. One in four patients with follicular thyroid cytology (THY3) has a thyroid carcinoma.
Mihai R; Parker AJ; Roskell D; Sadler GP
Thyroid; 2009 Jan; 19(1):33-7. PubMed ID: 18976164
[TBL] [Abstract][Full Text] [Related]
18. Hürthle cell neoplasms of the thyroid: Pathologic outcomes and ultrasonographic analysis.
Shin TJ; Rabbani CC; Murthy HD; Traylor K; Sim MW
Laryngoscope Investig Otolaryngol; 2020 Dec; 5(6):1254-1259. PubMed ID: 33364419
[TBL] [Abstract][Full Text] [Related]
19. A Retrospective Study of Clinicopathologic Outcomes of Nodules With Hürthle Cell Cytology and the Thyroid Nodule App (TNAPP) Ultrasound Recommendations.
Spagnuolo GM; Tierney HT; Laver NMV; Eldeiry LS
Endocr Pract; 2022 Jun; 28(6):593-598. PubMed ID: 35307577
[TBL] [Abstract][Full Text] [Related]
20. [Clinical experience in Hurthle cell tumors].
Francomano F; Napolitano L; Scipione P; Savini F; Bajocchi G; Angelucci D
G Chir; 1998; 19(11-12):449-52. PubMed ID: 9882947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]